U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with S

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
182855 Q4 2022 STEAROYL POLYOXYL-32 GLYCERIDES ORAL CAPSULE, EXTENDED RELEASE 8mg Correction
182884 Q3 2022 SODIUM ACETATE INTRAVENOUS INJECTION 984mg Correction
182885 Q4 2022 SODIUM ACETATE INTRAVENOUS INJECTION 56mg Correction
182886 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL-2000)-DISTEAROYL-RAC-GLYCEROPHOSPHOETHANOLAMINE INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 0.32 %w/v Correction
182887 Q4 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL 0.32 %w/v Correction
182888 Q3 2022 SORBITAN MONOOLEATE TOPICAL GEL 6mg Correction
182889 Q4 2022 SORBITAN MONOOLEATE TOPICAL GEL 4mg Correction
182890 Q3 2022 SORBITAN MONOSTEARATE TOPICAL CREAM, AUGMENTED 2.00 %w/w Correction
182891 Q4 2022 SORBITAN MONOSTEARATE TOPICAL CREAM, AUGMENTED 0.75 %w/w Correction
182892 Q3 2022 SORBITOL ORAL CAPSULE, LIQUID FILLED 51mg Correction
182893 Q4 2022 SORBITOL ORAL CAPSULE, LIQUID FILLED 25mg Correction
182894 Q3 2022 STARCH, CORN BUCCAL TABLET 16.60 mg Correction
182895 Q4 2022 STARCH 1500, PREGELATINIZED BUCCAL TABLET 9mg Correction
182896 Q3 2022 STARCH, CORN ORAL CAPSULE 5785mg Correction
182897 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE 5785mg Correction
182898 Q3 2022 STARCH, CORN ORAL CAPSULE, COATED, EXTENDED RELEASE 19mg Correction
182899 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, COATED, EXTENDED RELEASE 19mg Correction
182900 Q3 2022 STARCH, CORN ORAL CAPSULE, DELAYED RELEASE 216mg Correction
182901 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, DELAYED RELEASE 216mg Correction
182902 Q3 2022 STARCH, CORN ORAL CAPSULE, EXTENDED RELEASE 194mg Correction
182903 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, EXTENDED RELEASE 194mg Correction
182904 Q3 2022 STARCH, CORN ORAL CONCENTRATE NA Correction
182905 Q4 2022 STARCH 1500, PREGELATINIZED ORAL CONCENTRATE NA Correction
182906 Q3 2022 STARCH, CORN ORAL DROPS NA Correction
182907 Q4 2022 STARCH 1500, PREGELATINIZED ORAL DROPS NA Correction
182908 Q3 2022 STARCH, CORN ORAL PASTILLE NA Correction
182909 Q4 2022 STARCH 1500, PREGELATINIZED ORAL PASTILLE NA Correction
182910 Q3 2022 STARCH, CORN ORAL POWDER, FOR SUSPENSION 34mg Correction
182911 Q4 2022 STARCH 1500, PREGELATINIZED ORAL POWDER, FOR SUSPENSION 34mg Correction
182912 Q3 2022 STARCH, CORN ORAL SUSPENSION 900mg Correction
182913 Q4 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION 900mg Correction
182914 Q3 2022 STARCH, CORN ORAL SUSPENSION/ DROPS 90mg Correction
182915 Q4 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION/ DROPS 90mg Correction
182916 Q3 2022 STARCH, CORN ORAL TABLET 1116mg Correction
182917 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET 1116mg Correction
182918 Q3 2022 STARCH, CORN ORAL TABLET, CHEWABLE 180mg Correction
182919 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, CHEWABLE 180mg Correction
182920 Q3 2022 STARCH, CORN ORAL TABLET, COATED 256mg Correction
182921 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, COATED 256mg Correction
182922 Q3 2022 STARCH, CORN ORAL TABLET, DELAYED RELEASE 240mg Correction
182923 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, DELAYED RELEASE 130mg Correction
182924 Q3 2022 STARCH, CORN ORAL TABLET, EXTENDED RELEASE 184mg Correction
182925 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, EXTENDED RELEASE 184mg Correction
182926 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED 696mg Correction
182927 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED 696mg Correction
182928 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED, EXTENDED RELEASE 149mg Correction
182929 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED, EXTENDED RELEASE 149mg Correction
182930 Q3 2022 STARCH, CORN ORAL TABLET, ORALLY DISINTEGRATING 100mg Correction
182931 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, ORALLY DISINTEGRATING 100mg Correction
182932 Q3 2022 STARCH, CORN ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 10mg Correction
182933 Q4 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 21mg Correction
182934 Q3 2022 STARCH, CORN SUBLINGUAL TABLET 409mg Correction
182935 Q4 2022 STARCH 1500, PREGELATINIZED SUBLINGUAL TABLET 409mg Correction
182936 Q3 2022 SUCRALOSE NASAL SPRAY, METERED 358mg Correction
182937 Q4 2022 SUCRALOSE NASAL SPRAY, METERED 2mg Correction
182983 Q4 2022 SILICON DIOXIDE BUCCAL TABLET, EXTENDED RELEASE 0.46 mg Deletion
182984 Q4 2022 SILICON DIOXIDE ORAL LIQUID, EXTENDED RELEASE 2.03 mg/ 1.00 ml 24mg Deletion
182985 Q4 2022 SILICON DIOXIDE ORAL TABLET, COATED PARTICLES 25.00 mg/ 5.00 ml 200mg Deletion
182986 Q4 2022 SODIUM BENZOATE ORAL LIQUID, EXTENDED RELEASE 2.00 mg/ 1.00 ml 24mg Deletion
182987 Q4 2022 SODIUM BICARBONATE VAGINAL TABLET 43.00 mg Deletion
182988 Q4 2022 SODIUM LAURYL SULFATE BUCCAL TABLET, EXTENDED RELEASE 5.18 mg Deletion
182989 Q3 2022 SODIUM LAURYL SULFATE VAGINAL TABLET 5.00 mg Deletion
182990 Q4 2022 SODIUM PHOSPHATE, MONOBASIC BUCCAL FILM 0.47 mg Deletion
182991 Q4 2022 SODIUM POLYSTYRENE SULFONATE ORAL LIQUID, EXTENDED RELEASE 14.90 mg/ 1.00 ml 179mg Deletion
182992 Q4 2022 SODIUM POLYSTYRENE SULFONATE ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 43.75 mg 44mg Deletion
182993 Q4 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, COATED PARTICLES 10.00 mg 60mg Deletion
182994 Q4 2022 STARCH, CORN ORAL LIQUID, EXTENDED RELEASE 9.38 mg/ 1.00 ml 113mg Deletion
182995 Q3 2022 STARCH, CORN VAGINAL TABLET 49 mg 300mg Deletion
182996 Q4 2022 STARCH, CORN VAGINAL TABLET, FILM COATED 8.00 mg 8mg Deletion
182997 Q4 2022 SUCRALOSE ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 6.00 mg 6mg Deletion
182998 Q4 2022 SUCROSE ORAL LIQUID, EXTENDED RELEASE 0.80 mg/ 1.00 ml 10mg Deletion
183106 Q4 2022 STEAROYL POLYOXYL-32 GLYCERIDES ORAL CAPSULE 164mg MDE Replacement
183127 Q3 2022 SACCHARIN SODIUM ORAL CONCENTRATE 1.50 mg/ 1.00 ml MDE Replacement
183128 Q4 2022 SACCHARIN SODIUM ORAL CONCENTRATE 6mg MDE Replacement
183129 Q3 2022 SILICON DIOXIDE VAGINAL INSERT 2.50 mg MDE Replacement
183130 Q4 2022 SILICON DIOXIDE VAGINAL INSERT 8mg MDE Replacement
183131 Q3 2022 SIMETHICONE EMULSION TOPICAL CREAM 0.20 %w/w MDE Replacement
183132 Q4 2022 SIMETHICONE EMULSION TOPICAL CREAM 4mg MDE Replacement
183133 Q3 2022 SODIUM ALGINATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 320.00 mg MDE Replacement
183134 Q4 2022 SODIUM ALGINATE ORAL TABLET, FILM COATED, EXTENDED RELEASE 640mg MDE Replacement
183135 Q3 2022 SODIUM BENZOATE ORAL SUSPENSION 278.70 mg MDE Replacement
183136 Q4 2022 SODIUM BENZOATE ORAL SUSPENSION 37mg MDE Replacement
183137 Q3 2022 SODIUM BENZOATE ORAL SUSPENSION/ DROPS 3.00 mg/ 1.00 ml MDE Replacement
183138 Q4 2022 SODIUM BENZOATE ORAL SUSPENSION/ DROPS 15mg MDE Replacement
183139 Q3 2022 SODIUM BICARBONATE VAGINAL INSERT 43.00 mg MDE Replacement
183140 Q4 2022 SODIUM BICARBONATE VAGINAL INSERT 129mg MDE Replacement
183141 Q3 2022 SODIUM CHLORIDE INTRAMUSCULAR INJECTION, SUSPENSION 0.87 %w/v MDE Replacement
183142 Q4 2022 SODIUM CHLORIDE INTRAMUSCULAR INJECTION, SUSPENSION 26mg MDE Replacement
183143 Q3 2022 SODIUM CHLORIDE SOFT TISSUE INJECTION, SUSPENSION 0.22 %w/v MDE Replacement
183144 Q4 2022 SODIUM CHLORIDE SOFT TISSUE INJECTION, SUSPENSION 26mg MDE Replacement
183145 Q3 2022 SODIUM LAURYL SULFATE VAGINAL INSERT 5.00 mg MDE Replacement
183146 Q4 2022 SODIUM LAURYL SULFATE VAGINAL INSERT 15mg MDE Replacement
183147 Q3 2022 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS ORAL TABLET 96.00 mg MDE Replacement
183148 Q4 2022 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS ORAL TABLET 96mg MDE Replacement
183149 Q3 2022 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS SUBCUTANEOUS INJECTION 0.66 %w/v MDE Replacement
183150 Q4 2022 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS SUBCUTANEOUS INJECTION 20mg MDE Replacement
183151 Q3 2022 SORBIC ACID ORAL SUSPENSION 5.00 mg/ 5.00 ml MDE Replacement
183152 Q4 2022 SORBIC ACID ORAL SUSPENSION 22mg MDE Replacement
183153 Q3 2022 STARCH, CORN VAGINAL INSERT 210.00 mg MDE Replacement
183154 Q4 2022 STARCH 1500, PREGELATINIZED VAGINAL INSERT 147mg MDE Replacement
183155 Q3 2022 SUCROSE ORAL SUSPENSION/ DROPS 1250.00 mg/ 2.50 ml MDE Replacement
183156 Q4 2022 SUCROSE ORAL SUSPENSION/ DROPS 2250mg MDE Replacement
183157 Q3 2022 SUCROSE STEARATE ORAL CAPSULE, EXTENDED RELEASE 44.57 mg MDE Replacement
183158 Q4 2022 SUCROSE STEARATE ORAL CAPSULE, EXTENDED RELEASE 57mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: October 1, 2022
Database Last Updated: October 19, 2022

Back to Top